Tc Biopharm Plc Stock Buy Hold or Sell Recommendation
| TCBPW Stock | USD 0.01 0 15.79% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding TC BioPharm plc is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell TC BioPharm plc given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for TC BioPharm plc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out TC BioPharm Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as TCBPW and provide practical buy, sell, or hold advice based on investors' constraints. TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
TCBPW |
Execute TC BioPharm Buy or Sell Advice
The TCBPW recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TC BioPharm plc. Macroaxis does not own or have any residual interests in TC BioPharm plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TC BioPharm's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
TC BioPharm Trading Alerts and Improvement Suggestions
| TC BioPharm plc is way too risky over 90 days horizon | |
| TC BioPharm plc has some characteristics of a very speculative penny stock | |
| TC BioPharm plc appears to be risky and price may revert if volatility continues | |
| TC BioPharm plc has high likelihood to experience some financial distress in the next 2 years | |
| TC BioPharm plc has accumulated 1.8 M in total debt. TC BioPharm plc has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about TC BioPharm's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.91 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TC BioPharm plc has accumulated about 1.55 M in cash with (10.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| TC BioPharm plc has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: TC Biopharm Plc Sees Large Decrease in Short Interest - Defense World |
TC BioPharm Returns Distribution Density
The distribution of TC BioPharm's historical returns is an attempt to chart the uncertainty of TC BioPharm's future price movements. The chart of the probability distribution of TC BioPharm daily returns describes the distribution of returns around its average expected value. We use TC BioPharm plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TC BioPharm returns is essential to provide solid investment advice for TC BioPharm.
| Mean Return | 1.03 | Value At Risk | -23.13 | Potential Upside | 31.30 | Standard Deviation | 18.11 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TC BioPharm historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
TC BioPharm Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (205.0K) | (143.2K) | (310.2K) | (208.8K) | (240.1K) | (252.1K) | |
| Change In Cash | (208.5K) | 818.7K | 3.2M | (2.3M) | (2.7M) | (2.6M) | |
| Free Cash Flow | (3.5M) | (5.6M) | (15.5M) | (10.7M) | (9.6M) | (10.1M) | |
| Depreciation | 1.1M | 1.0M | 959.0K | 633.0K | 569.7K | 732.8K | |
| Other Non Cash Items | (1.6M) | 7.6M | (15.3M) | (7.3M) | (6.5M) | (6.2M) | |
| Capital Expenditures | 34.9K | 20.0K | 240.7K | 110.4K | 99.3K | 94.4K | |
| Net Income | (5.5M) | (13.6M) | (1.3M) | (5.9M) | (6.8M) | (7.1M) | |
| End Period Cash Flow | 748.0K | 1.6M | 4.8M | 2.5M | 2.8M | 2.3M |
TC BioPharm Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to TC BioPharm or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that TC BioPharm's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a TCBPW stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.24 | |
β | Beta against Dow Jones | 1.97 | |
σ | Overall volatility | 15.18 | |
Ir | Information ratio | 0.06 |
TC BioPharm Volatility Alert
TC BioPharm plc is showing large volatility of returns over the selected time horizon. TC BioPharm plc is a penny stock. Although TC BioPharm may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in TC BioPharm plc. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on TCBPW instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.TC BioPharm Fundamentals Vs Peers
Comparing TC BioPharm's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TC BioPharm's direct or indirect competition across all of the common fundamentals between TC BioPharm and the related equities. This way, we can detect undervalued stocks with similar characteristics as TC BioPharm or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TC BioPharm's fundamental indicators could also be used in its relative valuation, which is a method of valuing TC BioPharm by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare TC BioPharm to competition |
| Fundamentals | TC BioPharm | Peer Average |
| Return On Equity | -5.77 | -0.31 |
| Return On Asset | -0.98 | -0.14 |
| Number Of Shares Shorted | 7.83 K | 4.71 M |
| EBITDA | (13.61 M) | 3.9 B |
| Net Income | (5.91 M) | 570.98 M |
| Cash And Equivalents | 1.55 M | 2.7 B |
| Cash Per Share | 0.08 X | 5.01 X |
| Total Debt | 1.8 M | 5.32 B |
| Current Ratio | 0.18 X | 2.16 X |
| Book Value Per Share | 81.06 X | 1.93 K |
| Cash Flow From Operations | (10.54 M) | 971.22 M |
| Earnings Per Share | (0.75) X | 3.12 X |
| Number Of Employees | 41 | 18.84 K |
| Beta | 0.012 | -0.15 |
| Total Asset | 8.93 M | 29.47 B |
| Retained Earnings | (38.84 M) | 9.33 B |
| Working Capital | 950.33 K | 1.48 B |
| Net Asset | 8.93 M |
Note: Acquisition by Randall Mark Edward of 70000 shares of TC BioPharm subject to Rule 16b-3 [view details]
TC BioPharm Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TCBPW . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.22 | |||
| Daily Balance Of Power | 0.5172 | |||
| Rate Of Daily Change | 1.16 | |||
| Day Median Price | 0.0117 | |||
| Day Typical Price | 0.0114 | |||
| Market Facilitation Index | 0.0029 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 0.0015 |
About TC BioPharm Buy or Sell Advice
When is the right time to buy or sell TC BioPharm plc? Buying financial instruments such as TCBPW Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having TC BioPharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals Funds Thematic Idea Now
Precious Metals Funds
Funds or Etfs that invest in entities that are involved in mining, processing or dealing of precious metals. The Precious Metals Funds theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.